Scan to downloadJ-Pharma Co.,Ltd. (520A) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-11 | — | Notice Regarding the Recognition of Non-operating Expenses (Foreign Exchange Losses) | |
| 2026-11-11 | Earnings Release | Non-consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP) | |
| 2026-10-30 | — | Notice of Grant approval and Commencement of the Grant-Funded Project under AMED’s GRiT Program | |
| 2026-10-05 | — | J-Pharma Selected for Funding under AMED's Global Research and Development Support Project for the Treatment of Intractable/Rare Diseases | |
| 2026-09-25 | — | J-Pharma Enters into Non-Binding Term Sheet with European Biotech Company for JPH034 | |
| 2026-08-12 | Earnings Release | Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP) | |
| 2026-08-12 | — | Notice Regarding Completion of Payment for Issuance of New Shares as Restricted Stock Compensation to Directors and Executive Officers and Adjustment | |
| 2026-07-13 | — | Notice Regarding Issuance of New Shares as Restricted Stock Compensation to Directors and Executive Officers |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.